OncLive - Bringing the Oncology Community Together

Home

Targeted Therapies

Hennessy's Highlights

January 2012

Conference Highlights

Peripheral Neuropathy Profile More Favorable With Eribulin

2 Landmark Trials Suggest Changes in Practice; Brachytherapy Controversy Attracts Attention

From the Editor

Molecular Target Testing: Advances Prompt Questions About Costs and Strategies

Pathways

5 Questions for Yuri Lazebnik, PhD

What Turns a Good Cell Bad? Exploiting the Hallmarks of Cancerous Cells

Specialty Focus

Addition of Bevacizumab May Help in Nasopharyngeal Cancer

Lenalidomide Plus Docetaxel: Phase III Results Fall Short

Electronic Ordering System Improves Chemotherapy Care

Oncofertility, Osteonecrosis Emerge as Patient Concerns

HPV Plays Growing Role in Evaluating Therapies

Conference Features Debates on Clinical Controversies

Bevacizumab Delivers Ovarian Cancer Benefit But Not OS Upgrade

IPCC Conference to Focus on Issues Facing Clinicians

Cover Story

Looking Forward: Experts Discuss Exciting Trends in 2012 Oncology Drug Pipeline

External Resources

American Journal of Managed Care
HCPLive
PainLive
Pharmacy Times
Physicians' Education Resource
Physician's Money Digest

OncLive Resources

Archives
Blogs
OncLive TV
Oncology Nurses
Publications
Specialties
Web Exclusives

About Us
Advertise
Advisory Board
Contact Us
Forgot Password
Privacy Policy
Terms & Conditions

Intellisphere, LLC
666 Plainsboro Road
Building 300
Plainsboro, NJ 08536
P: 609-716-7777
F: 609-716-4747

Copyright HCPLive 2006-2012
Intellisphere, LLC. All Rights Reserved.